Login / Signup

Maximizing the benefits of using biosimilars in Egypt.

Ahmad Nader FasseehBaher ElezbawyKareem Ahmed El-FassMary GamaIAhmed SeyamNoha HayekNagwan Abdel RahmanSohir AbdelhamidNader FasseehAmr Shafik SaadAhmed ElagamyAkram MahmoudAmal Samir SedrakKhaled ElshazlyMariam EldebeikyMonica TalaatNoura Maher MohamedRania Ahmed AbdelazizRemonda RefaatShaimaa AkeelSherif AbazaZoltán Kaló
Published in: Journal of pharmaceutical policy and practice (2023)
A summarized national framework policy recommendation for biosimilars was created by local experts from the main public healthcare entities in Egypt. These recommendations coincide with the international policies adopted across different countries that aim to improve patient access while sustaining health expenditure.
Keyphrases
  • healthcare
  • public health
  • mental health
  • case report
  • quality improvement
  • clinical practice
  • health information
  • emergency department
  • climate change
  • social media
  • adverse drug